Radiation Oncology

Latest News

Data support incorporating volumetric PET biomarkers into toxicity risk prediction for patients receiving CAR T-cell therapy for LBCL.
High Tumor Volume Confers CAR T-Cell Therapy Toxicity Risk in LBCL

June 30th 2025

Data support incorporating volumetric PET biomarkers into toxicity risk prediction for patients receiving CAR T-cell therapy for LBCL.

Compared with 18F-FDG, the use of 68Ga-NODAGA-LM3 appears to favor bone and brain lesion detection among patients with small cell lung cancer.
68Ga-NODAGA-LM3 May Effectively Evaluate Small Cell Lung Cancer Responses

June 28th 2025

Stereotactic online adaptive magnetic resonance guided radiation therapy was well tolerated and maintained stable QOL in patients with PDAC for up to 1 year.
Magnetic Resonance Guided Radiation May Be Beneficial in Nonmetastatic PDAC

June 25th 2025

Retrospective analysis at SNMMI 2025 revealed α-FRT with 225AC-3BP-3940 was well tolerated and elicited responses in pretreated metastatic breast cancer.
225AC-3BP-3940 Is Safe, Shows Activity in Heavily Pretreated Advanced Breast Cancer

June 24th 2025

Use of PET-guided radiotherapy may enable the opportunity to incorporate biological information into the planning and delivery of radiation.
PET-Guided Radiotherapy Successfully Manages Lung and Bone Tumors

June 23rd 2025

Video Series
Video Interviews
Podcasts
A dedicated, well-trained, and expert staff at the Ivy Brain Tumor Center enables the facility to be at the forefront of cutting-edge radiosurgery treatment.
Experts from Sibley Memorial Hospital discuss how multidisciplinary work has enhanced outcomes such as survival and resource use at their institution.
Uterine transposition, a surgical approach preserving fertility by moving the uterus out of the radiation field, may improve gynecologic cancer outcomes.
Experts from Vanderbilt Medical Center review mechanisms, supporting data, and patient cases associated with the use of IORT in pancreatic cancer.
AI tools may show utility in areas such as prostate diagnostic imaging, pathology, and treatment outcome predictions.
Terence T. Sio, MD, MS, highlights advances such as proton beam radiotherapy that may improve outcomes for those with non–small cell lung cancer.
Timothy Chen, MD, highlights how technologies such as ZAP-X and proton therapy may improve outcomes for patients with cancer.

More News